The AGE Reader has been validated in over 300 peer-reviewed publications. Please find below a selection of key publications for the different indications of the AGE Reader.
Kidney disease:
The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study. Shardlow A, McIntyre NJ, Kolhe NV, et al. PLoS Med. 2020;17(7):e1003163. doi:10.1371/journal.pmed.1003163
Skin autofluorescence and malnutrition as predictors of mortality in persons receiving dialysis: a prospective cohort study. Viramontes Hörner D, Selby NM, Taal MW. J Hum Nutr Diet. 2020;33(6):852-861. doi:10.1111/jhn.12764
Skin autofluorescence associates with vascular calcification in chronic kidney disease. Arterioscler Thromb Vasc Biol.Wang AYM, Wong CK, Yau YY, Wong S, Chan IHS, Lam CWK. 2014;34(8):1784-1790. doi:10.1161/ATVBAHA.114.303378
Diabetes:
Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes. Boersma HE, van Waateringe RP, van der Klauw MM, et al. BMC Endocr Disord. 2021;21(1):14. doi:10.1186/s12902-020-00676-4
Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus. Yozgatli K, Lefrandt JD, Noordzij MJ, et al. Diabet Med. Published online April 23, 2018. doi:10.1111/dme.13651
Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Meerwaldt R, Lutgers HL, Links TP, et al. Diabetes Care. 2007;30(1):107-112. doi:10.2337/dc06-1391
Cardiovascular disease:
Surgery patients:
General population:
Would you like to learn more about our products? Request any information you wish to receive here.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.